Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Pfizer (PFE) hired Seng Hing Cheng as senior vice president and chief scientific officer of its rare disease research unit. Previously, he worked at the Genzyme unit at Sanofi (SNY), where he was global head of research for rare disease.